Every 10-Q that Horizon Space Acquisition II Corp. (HSPT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow HSPT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HSPT filings page.
Horizon Space Acquisition II Corp. reported a small net loss of $29,122 for the quarter ended March 31, 2026, as interest income of $588,076 on its Trust investments was more than offset by formation and operating costs of $364,905 and interest expense of $252,293.
The SPAC redeemed 3,219,311 ordinary shares for $34,221,276, reducing the Trust Account to $39,390,860 and leaving a working capital deficit of $1,784,554. It continues to pursue the SL Bio business combination, supported by a $7,800,000 PIPE and multiple extension deposits, but management discloses substantial doubt about the company’s ability to continue as a going concern if a deal is not completed by the current deadline.
Horizon Space Acquisition II Corp. (HSPT) filed its quarterly report for the period ended September 30, 2025. The SPAC remains pre‑revenue, with activity centered on its IPO proceeds and proposed merger plans. Net income was $615,026 for the quarter, driven by $739,550 of interest and dividend income from the Trust Account, offset by $124,524 of formation and operating costs. For the nine months, net income totaled $1,308,900.
The Trust Account balance was $71,540,599, while cash outside the trust was $66,627. Ordinary shares subject to possible redemption were 6,900,000 at redemption value; non‑redeemable ordinary shares outstanding were 2,180,000. The company reported a working capital deficit of $436,294 and recorded accretion to redemption value of $739,550 in the quarter.
Management disclosed substantial doubt about the company’s ability to continue as a going concern. The combination deadline is November 18, 2025 (extendable to May 18, 2026 with sponsor deposits of $690,000 per three‑month extension, up to $1,380,000). On May 9, 2025, HSPT entered a business combination agreement with SL Science Holding Limited and SL Bio Ltd. The sponsor provided a $300,000 non‑interest bearing working capital note on July 5, 2025.
Horizon Space Acquisition II Corp. is a Cayman Islands blank‑check company formed to complete a business combination. The company completed an IPO and related private placements that produced gross proceeds of $69,000,000 and, as of June 30, 2025, held $70,801,049 in a Trust Account that will fund an initial business combination. Cash outside the Trust was $26,030 and the company reported a working capital deficit of $311,770.
The company reported net income of $221,282 for Q2 2025 and $693,874 for the six months ended June 30, 2025, primarily from interest and dividend income on the Trust Account of $730,448 (Q2) and $1,456,519 (six months). On May 9, 2025, the company entered into a business combination agreement with SL Bio (through PubCo), and on July 5, 2025 the sponsor provided a $300,000 unsecured promissory note for working capital. Management disclosed that conditions raise substantial doubt about the company’s ability to continue as a going concern and plans to address this through working capital loans.